All Activity

I just found this blog and have high hopes for it to continue. Keep up the great work, its hard to find good ones. I have added to my favorites. Thank You. Futebol português

I simply believed it might be a concept to publish in case other people had been having issues studying however I'm just a little uncertain basically 'm permitted to place titles as well as handles upon right here. togel slot That i taken aback when using the exploration everyone intended to get this to selected present astounding. Terrific process! togel macau That you're allowed to place leaders, however is not one way links, except when they're just authorised together with regarding niche. bandar togel Actually sound, great, fact-filled details the following. The content Don't ever fail, understanding that undoubtedly is valid the following at the same time. An individual constantly lead to an appealing examine. Is it possible to notify Now i'm pleased?: )#) Maintain the nice posts. akongcuan bandar Thanks a lot for the purpose of rendering up to date update versions about the challenge, I just await read through further. giftcardmall/mygift check balance Maintain the nice perform, My partner and i examine handful of content with this internet site and also I do believe your net website will be genuine intriguing and contains received sectors regarding great details. olxtoto

The retail giant Target is soft launching sales of THC-infused beverages at select stores in Minnesota, an executive of one cannabis drink company participating in the rollout and other industry leaders told Marijuana Moment. In one of the latest examples of the normalization of cannabis in mainstream commercial marketing, Target’s move in Minnesota—where the company is headquartered—reportedly involves putting a dozen THC drink brands on shelves in 10 select stores in the state. The move comes as Congress is debating legislation to recriminalize hemp-derived products with a quantifiable amount of THC, and as states across the country continue to evaluate their own laws. “Given everything that’s going on around hemp and the conversations about regulation versus prohibition, Target getting into it now is monumental,” Jason Dayton, co-founder of Trail Magic, told Marijuana Moment. “And this is a moment that shows that regulation work.” “I think all of us, collectively, would say we want more regulation—not less,” he said. “We want age-gating, we want testing, we want all of the rules of the road that have allowed the alcohol industry to become a $250 billion a year category, with everything included: Countless jobs and tax revenue associated with that.” The THC drink brands that are being sold at Target of Friday include Birdie, Cann, Gigli, Hi Seltzer, Indeed, Señorita, Stigma, Surly, Trail Magic, Wonder, Wyld and Wynk, according to Dayton. Photo via Jason Dayton, Trail Magic. Adam Terry, CEO of Cantrip, said that while he’s “bummed” his company is not part of the launch, the development is “still HUGE for the category and big props to those in the set.” Marijuana Moment reached out to Target and to some of the other drinks brands for comment, but representatives were not immediately available. “I’ve long wondered when the heavyweights of retail, distribution, and alcohol would decide to wade into hemp beverages,” Aaron Edelheit, CEO of Mindset Capital, said in a blog post on Friday. “While we’ve seen major state-level distributors and large alcohol retailers like Total Wine enter the space, we haven’t yet seen a true retail behemoth take the plunge. That changed today.” Target has started selling hemp beverages in a 10 store pilot in Minnesota today. This is monumental news for the hemp beverage space & I'm super excited as one of my portfolio brands & personal favorites, Trail Magic, is part of the launch. What a great day for hemp beverages! — Aaron Edelheit (@aaronvalue) October 10, 2025 Whether the test pilot leads to a more national expansion of hemp beverages at Target locations beyond Minnesota is yet to be seen. But the move also comes at a precipitous time in the state and federal hemp policy debate, with some lawmakers angling for a ban of cannabis products containing any amount of THC—despite the federal legalization of the crop and its derivatives under the 2018 Farm Bill, which was signed into law by President Donald Trump during his first term. In Minnesota in particular, hemp beverages have been a mainstay even before the state moved to legalize marijuana for adult use. Gov. Tim Walz (D) signed legislation in 2022 making it so all hemp-derived cannabinoids including CBD could be legally sold in food items, beverages, topicals and more—as long as the products contain less than the federal limit of 0.3 percent THC. Edible and beverage products are limited to a total of 5 mg THC per serving and 50 mg per package. About a year later, former Minnesota House Majority Leader Ryan Winkler (DFL), who championed the state’s legalization law over multiple sessions, announced plans to launch his own hemp beverage company. The mainstreaming of cannabis beverages comes as a new polls shows that a majority of Americans believe marijuana represents a “healthier option” than alcohol—and that most also expect cannabis to be legal in all 50 states within the next five years. Another survey found that four in five adults who drink cannabis-infused beverages say they’ve reduced their alcohol intake—and more than a fifth have quit drinking alcohol altogether. Target isn’t alone in joining the cannabis train as state laws continue to evolve. Home Depot, one of the largest employers in the United States, last year shifted its employee drug testing policies to remove cannabis from screening panels entirely and stop pre-employment drug testing of most of its workers, according to a document obtained by Marijuana Moment. In 2022, Amazon, the second largest private employer in the U.S., also backed a Republican-led bill to federally legalize, tax and regulate marijuana. It previously expressed support for a separate, Democratic-led legalization bill. Amazon has also worked to adapt to changing marijuana policies internally as it’s backed congressional reform, enacting an employment policy change in 2021 to end drug testing for cannabis for most workers, for example. Meanwhile, Veterans of Foreign Wars (VFW) of the United States recently entered a first-of-its-kind partnership with a hemp THC beverage company, with a licensing branding deal that will support a variety of veterans services and promote cannabis drinks as a potential alcohol alternative with the drinks being available at VFW posts across the country. Separately, while Target is apparently moving into the THC drink space, the airline Virgin Atlantic denied satirical and false claims earlier this year from a cannabis beverage company about a deal to sell its THC-infused beverages on flights. The post Target Begins Selling THC-Infused Cannabis Drinks As Congress Debates Possible Hemp Law Reversal appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Candidates for Virginia governor clashed on marijuana policy at a debate on Thursday—with the Republican nominee saying that while she supports medical cannabis, she had a zero-tolerance policy for employee consumption as the owner of a utility repair business. She feared that workers who tested positive for THC while working with gas and electricity would “blow everything up,” the GOP contender said. During a gubernatorial debate, both gubernatorial candidates—former U.S. Rep. Abigail Spanberger (D-VA) and current Lt. Gov. Winsome Earle-Sears (R)—were pressed on marijuana policy issues. Spanberger, who supports legalization, was asked about public safety considerations for the establishment of a potential cannabis market that she’s pledged to support if elected. The candidate said simply that “it’s important that there be transparency in what is available on the market.” “As a former federal agent who worked narcotics cases, as a CIA officer who tracked transnational criminal organizations, as the only person on stage who’s had a bill signed into law by President Trump restricting fentanyl flowing into our country and tightening our border security, and as the only person on stage with the endorsement of the Police Benevolent Association, it is extraordinarily important that we have transparency and that there is a clear market in order to be enforced,” she said. The moderator then directed a question at Earle-Sears, pointing out that under the administration in which she currently serves, the governor has twice vetoed legislation to create a commercial marijuana market in the commonwealth, despite the enactment of legalization of possession and cultivation by adults. Asked whether she would take a different approach and allow for commercial sales if presented with such a bill, the lieutenant governor said, “I believe in medicinal marijuana. I believe it has value.” “But, you know, I had a business—and when I had my business and my employees came up positive for marijuana, they couldn’t work for me,” she said. “They couldn’t drive my trucks. They couldn’t go in and repair anything. We were working on gas. We’re working on electric. We can’t afford to have people who are working and they don’t know what they’re doing. They’ll blow everything up.” Earle-Sears has staunchly opposed allowing Virginia to create a commercial adult-use cannabis market, going so far as to say that marijuana is a gateway drug and suggesting that legalization is “decimating communities.” Spanberger, for her part, told Marijuana Moment last month that, “as Virginia takes steps toward creating a legalized retail market for cannabis,” it needs a “clear strategy to set up a market that is safe for consumers, transparent for businesses, and fair to entrepreneurs.” She added that it’s her stance that “revenue from commercial cannabis products must return to Virginia communities and be reinvested for purposes like strengthening our public schools.” If elected, Spanberger said she will “work with leaders in the General Assembly to find a path forward that both prioritizes public safety and grows Virginia’s economy.” Meanwhile, earlier this week a Virginia legislative commission convened another meeting where lawmakers and advocates discussed plans to prepare the state to legalize recreational marijuana sales. Del. Paul Krizek (D), chair of the Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market, began Monday’s meeting by noting it would be the second-to-last for the body—saying that at the next and final one in December, members will “go over the bill that we are working on now.” The plan is for the body to suggest a proposal that the full legislature can consider passing in the 2026 session that begins in January. Use and possession of marijuana has been legal in Virginia since 2022, but retail sales remain forbidden—a situation that’s helped fuel a multibillion-dollar illicit market. Despite efforts by Democrats in past years to legalize and regulate the retail system, Gov. Glenn Youngkin (R) has stood in the way of the reform, vetoing proposals passed by lawmakers during each of the last two sessions. At the legislative commission’s first meeting in July, members discussing broad regulatory considerations and other issues related to THC potency, the hemp market and more. In August, the panel focused on cannabis taxes and revenue. Meanwhile, a top Democratic Virginia senator recently said the state should move forward with legalizing recreational marijuana sales—in part to offset the Trump administration’s cuts to federal spending in support of states. While the legislature has twice passed bills to create a regulated commercial cannabis market after the state legalized possession and use by adults in 2022, Youngkin vetoed both proposals. But with anticipated increases in spending in Virginia resulting from various federal policy initiatives such as the withdrawal of federal welfare dollars to states, Senate President Pro Tem Louise Lucas (D) said it’s time to get serious about alternative revenue, which should include legalizing marijuana sales. Photo courtesy of Philip Steffan. The post Virginia Gubernatorial Candidates Clash On Marijuana At Debate, With GOP Nominee Worrying Users Could ‘Blow Everything Up’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A GOP senator says it’s time to create a regulatory framework for marijuana with a federal excise tax and allow states to “opt in” to legalization—stating that he’s “not an anti-cannabis person” but stressing that certain rules should be implemented. Sen. Thom Tillis (R-NC) might not be the voice most would expect to back comprehensive federal marijuana reform, but he’s been ringing the bell for months as he makes the case for regulation over prohibition. Part of his position is informed by concerns he has with a North Carolina-based tribe that legalized cannabis and markets the product despite the fact that the state itself has not yet moved forward with marijuana reform. In an interview with McClatchy that was published on Thursday, Tillis said, “We need to get rid of flavorings, eliminate Chinese imports, let states opt in, if they choose, and have rules of the road with excise tax and everything else.” Discussing the Eastern Band of Cherokee Indians (EBCI) that legalized marijuana within its territory in North Carolina, the senator said he’s displeased with the marketing approach that’s extended beyond the tribe’s borders. “I mean, gosh, when you’re doing the ads in Charlotte: ‘One of the country’s biggest dispensaries,’ and you’ve got a really cute app and you’re advertising all these fruity names and everything, and you’re an island—I mean unless you’re going there and having one hell of a weekend, we all know that people are taking it and bringing it back,” he said. “People need to know the minute they leave the boundary, they’re breaking the law.” “There are people lined up, the traffic is stopped. It’s amazing,” Tillis said, referencing the tribe’s dispensary. “I’m not an anti-cannabis person, but you’ve got to do it legally.” Michell Hicks, principal chief of EBCI, pushed back, saying that the tribe “operates squarely within the law” and saying that the senator “has chosen to ignore that truth to advance his own political agenda.” “Our operations are fully compliant with federal and tribal law, guided by safety, transparency, and accountability,” Hicks said. “Senator Tillis’ attacks are not about legality; they are about ego. To suggest the EBCI would endanger children through marketing or sales practices is inaccurate and it is offensive to the values that guide our tribe.” Tillis, for his part, also raised similar concerns about the tribe’s cannabis operation during a Senate Judiciary Committee hearing with Attorney General Pam Bondi on Tuesday. He said he has “no problem with” the legalization of sales in that territory generally—but that he still finds “concerning” with respect to the conflict between state and federal marijuana laws. “Nearly three dozen states [have] either medical, recreational or hybrid” cannabis models, the senator said. “But this kind of feels like to me, the way the tobacco industry got attacked for advertising to young people.” “This is just this worries me, because it’s a money-making enterprise. It kind of seems like it’s preying on younger people,” he said, pointing to an app that he claims allows people in states that prohibit cannabis to order marijuana products in a legal jurisdiction and then pick it up after crossing state boundaries. Tillis also said last month that the federal government needs to “step up” and explore a regulatory framework for marijuana—and that should include a pathway to explore the “efficacy” of cannabis for certain health conditions. At a separate Judiciary Committee hearing in June, Tillis said opponents of marijuana legalization “have lost” the fight to maintain prohibition and that “it’s time” for lawmakers to address that reality by creating a regulatory framework treating cannabis “in the same way that we do with alcohol and tobacco,” so that states can set their own policies without federal intervention. Back in February, the senator also raised the issue during a Senate Banking Committee hearing, saying “we should reexamine [federal marijuana laws].” But at the same time, “we damn sure shouldn’t do it by passing” legislation that would simply prevent federal regulators from penalizing banks that work with state-legal cannabis businesses. Tillis also said last December that he’s hopeful Congress will have a “discussion” about potentially creating a federal regulatory framework for marijuana in 2025, though he added that he personally wouldn’t vote to federally legalize cannabis. Last year, the senator also said he supports creating a “comprehensive regulatory framework that treats marijuana just like tobacco,” arguing that “the federal government needs to figure out a safe way to allow this market to occur.” Tillis in April joined Sen. Ted Budd (R-NC) in asking federal, state and local officials what steps they were taking to enforce marijuana prohibition as an Indian tribe prepared to launch recreational cannabis sales on its lands within North Carolina. Separately, Trump’s nominee for White House drug czar, Sara Carter, told members of the Judiciary Committee at a hearing last month that the administration is keeping “all options” on the table as it continues to consider the marijuana rescheduling proposal, while describing cannabis reform as a “bipartisan issue.” The committee advanced the nominee’s confirmation to the floor on Thursday. The post GOP Senator Wants To Let States ‘Opt In’ To Marijuana Legalization And Set A Federal Tax On It, Saying He’s ‘Not An Anti-Cannabis Person’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Texas hemp and alcohol industry stakeholders are urging officials to ramp down proposed hemp regulations to provide more leniency as the state implements new rules to prevent youth access to intoxicating products. At a Texas Alcoholic Beverage Commission (TABC) public meeting on Thursday, the agency presented draft rules that businesses would need to follow in order to sell consumable cannabinoid products. But while there was consensus around the underlying ban on sales to people under 21, there was pushback against certain proposed definitions and penalties. The purpose of the meeting was to gain that stakeholder feedback as TABC works to permanently codify rules that the agency issued last month in emergency form in response to an executive order from Gov. Greg Abbott (R). The emergency policy is already in effect but is set to expire within months. “Our intent is to propose these rules at the upcoming meeting on November 18,” TABC senior counsel Matthew Cherry said, adding that if the commission does vote to propose the rules, another public hearing and comment period will be held before they’re potentially adopted. Among the more controversial provisions of the proposed rules is an automatic revocation of a business’s liquor license if regulators identify a violation of the age-gating policy. Some participants at Thursday’s meeting, including Total Wine Senior Vice President Robert Shaffer, argued that it may be a “better approach” to focus the penalty on a business’s separate hemp license, rather than imperiling a liquor license unrelated to the hemp violation. In general, there were questions about the apparent lack of due process considerations of the proposed penalties—without a clear mechanism by which licensees could contest charges—which one stakeholder said would constitute a violation of the Texas Administrative Procedure Act (APA). There was also talk about the strict compliance requirements for ID verification, with Shaffer pointing out that some elderly alcohol customers are offended when they’re required to present identification showing they’re of age. Cherry said all of the comments will be taken under advisement by the commission, but as contemplated in the proposed rule, businesses would be required to ID every customer who purchases a hemp THC product without discretion. Mark Borda, executive director of the Hemp Business Council, also expressed concerns “about compliance and market impact—specifically the chilling effect or de facto ban, the heavy handed treatment with license revocation.” “One-and-done would seem to really give people cause to pause in carrying these products. I don’t know if that’s intended or not,” he said. In the agenda for the meeting, TABC said the proposed rules “are being proposed to implement Governor Abbott’s directive in Executive Order GA-56 to prohibit the sale of consumable hemp products to minors,” calling the rules “substantively similar to Emergency Rule 51.1 and Emergency Rule 51.2.” Last week, the Department of State Health Services (DSHS) adopted a set of similar emergency rules meant to prevent the sale of intoxicating hemp products to people under 21. The reason that two agencies are issuing similar rules is that TABC only regulates retailers that sell alcohol, such as liquor stores and certain convenience and grocery stores, and thus has no jurisdiction over smoke shops and other places that sell hemp products but not alcohol. Just two days before Thursday’s TABC meeting, the governor called on the state Department of Public Safety (DPS) to escalate enforcement against smoke shops that are violating laws related to the sale of intoxicating hemp products, including the recently enacted emergency rule barring people under 21 from purchasing cannabis. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The governor’s executive order was issued following unsuccessful efforts in the legislature to impose an outright ban on hemp products with any quantifiable amount of THC. Meanwhile this month, the head of the Texas Department of Agriculture (TDA) pushed back against a GOP senator’s “incorrect assertions” about the state’s regulatory compliance with federal hemp laws. But he also signaled that changes may be coming to measure “total THC” to determine the legality of hemp products in a way that some stakeholders worry could negatively impact the industry. Separately, a recent survey from a GOP pollster affiliated with President Donald Trump found that Texas Democratic and Republican voters are unified in their opposition to the hemp ban proposal. Photo courtesy of Brendan Cleak. The post Texas Hemp And Alcohol Stakeholders Push Back On ‘Heavy Handed’ Proposed Rules In Meeting With Officials appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

President Donald Trump’s pick for White House drug czar dodged a series of written questions from senators about her position on marijuana rescheduling, medical cannabis legalization and racial disparities in drug enforcement. Ahead of a Senate Judiciary Committee vote on Thursday to advance the nomination of Sara Carter Bailey as director of the Office of National Drug Control Policy (ONDCP), the nominee submitted responses to a variety of questions from members, including multiple that dealt with cannabis. Similar to how to navigated questions about rescheduling during an in-person hearing last month, Bailey provided largely vague answers about the topic when asked by Sens. Cory Booker (D-NJ) and Dick Durbin (D-IL). That’s despite her previous statements supporting medical cannabis access prior to her nomination. Asked simply whether she supports the rescheduling of cannabis—as Trump previously endorsed on the campaign trail and said in late August he’d be deciding on within weeks—Bailey said, if confirmed, “I will comply with all federal laws and fulfill all statutory responsibilities of the ONDCP. I will also work with the interagency to ensure an examination of all facts and evidence as part of any scheduling or policy actions.” Citing comments the nominee made on a podcast episode, where she acknowledged the medical benefits of cannabis, Durbin asked whether she intended to “work to legalize medical marijuana on the federal level.” “If confirmed as Director, I will comply with all federal laws and fulfill all statutory responsibilities of the ONDCP,” she said, mirroring her response to the rescheduling question. “I will also work with the interagency to ensure an examination of all facts and evidence as part of any scheduling or policy actions.” While there’s nothing in federal statute precluding the ONDCP director from supporting administrative rescheduling proposals, the law does dictate that the official is barred from promoting the legalization of any Schedule I drugs under the Controlled Substances Act (CSA). In April, Democratic congressional lawmakers announced the filing of a bill that would remove that restriction. It has not yet advanced in the GOP-controlled Congress, however. Durbin also asked the nominee if she agrees “people of color have been disproportionately harmed by drug prosecutions,” and she offered a curious response, seemingly disagreeing despite the preponderance of evidence that Black and brown people have been more aggressively targeted over drugs compared to white people. “I believe that all communities have suffered as a result of illicit narcotics with data showing that certain drugs are more prevalent in some communities,” she said. Then, asked what she would do about the racial disparity issue, Bailey said she would simply “commit to ensuring effective, timely, evidence-based treatment is available to all Americans.” “At the same time, through collaboration with the Department of Justice, I will support U.S. Attorneys to hold all drug traffickers accountable,” she said. Booker also leaned into the rescheduling issue in his questions for the record (QFRs). Specifically, he pressed the nominee on whether “prosecutors or scientists and doctors” are better qualified to “conduct the scientific and medical evaluations of drugs.” “As stated at the hearing, if confirmed I will work with all relevant interagency stakeholders to ensure an examination of all facts and evidence,” she said. “Under the CSA, scientists and doctors use a comprehensive approach in balancing potential risks and benefits of any substance, and the HHS Secretary provides a recommendation to the Attorney General.” Booker then asked if Bailey would “assign more weight to a scheduling recommendation from HHS based on its scientific and medical evaluation of a drug rather than DEA’s opinion.” “As stated at the hearing, I support the process under the CSA, and if confirmed I will work with all relevant interagency stakeholders to ensure an examination of all facts and evidence,” she said. The senator additionally inquired as to whether the nominee would “support additional federal funding for overdose prevention centers” if confirmed. But it’s not clear what he meant by that line of questioning, as advocates generally refer to overdose prevention centers as locations where people can safely use currently illicit drugs under medical supervision with treatment resources. The Justice Department has long maintained that statute prohibits such facilities, fighting local attempts to institute them in court. In any case, Bailey said she doesn’t support additional funding; rather, she generally backs “preventing overdoses and all harms caused by drugs.” “Each overdose save is an opportunity to connect a person to treatment and give them hope,” she said. “I also fully support the President’s executive orders.” Booker also asked whether the nominee believes the “war on drugs approach has failed to reduce overdose deaths.” “Our approach will be balanced: preventing the production of illicit drugs overseas and their movement across our borders and into our communities; holding accountable those who traffic in illicit drugs and their raw materials, as well as those who facilitate the illicit drug trade; preventing drug use before it starts; saving the lives of those who overdose; and providing access to evidence-based treatment leading to long-term recovery for everyone who needs it,” Bailey said. A former journalist known for her coverage of drug cartels, Bailey also recently advised senators that the administration is keeping “all options” on the table as it continues to consider a pending marijuana rescheduling proposal, while describing cannabis reform as a “bipartisan issue.” Given the role of the ONDCP director in setting and carrying out the administrative agenda on drug policy issues, the fact that Bailey has gone on the record enthusiastically endorsing medical cannabis in the past is welcome news for advocates. Trump endorsed rescheduling—as well as marijuana industry banking access and a Florida legalization ballot initiative–on the campaign trail ahead of his second term. But his most recent comments in late August about the timeline for a rescheduling decision gave a more ambiguous impression of his position on the issue. While Bailey has spoken often about various marijuana policy issues—focusing attention on illicit trafficking and illegal grow operations on U.S. land, for example—her public comments on how she personally feels about the topic have been limited. What she did say last year in an episode of her podcast, The Sara Carter Show, signaled that she draws a distinction between legally regulated and illicitly supplied marijuana. “I don’t have any problem if it’s legalized and it’s monitored,” she said. “I mean, I may have my own issues of how I feel about that, but I do believe that cannabis for medicinal purposes and medical reasons is a fantastic way of handling—especially for people with cancer and other illnesses, you know—of handling the illness and the side effects of the medication and those illnesses. So I’m not saying we’ve gotta make it illegal.” If Bailey is ultimately confirmed by the Senate, she will become the second drug czar in a row who has voiced support for medical marijuana, following former President Joe Biden’s ONDCP director Rahul Gupta, who worked as a consultant for a cannabis businesses and also oversaw implementation of West Virginia’s medical marijuana program. Bailey has separately sounded the alarm about the risk of pesticides and other contaminants in marijuana grown and sold by Chinese cartels—an issue that was recently taken up by a House committee. Last year, the nominee talked about the issue with Derek Maltz, a then-retired Drug Enforcement Administration (DEA) official who is temporarily served as acting administrator of the agency prior to the confirmation of Trump’s permanent pick, Terrance Cole. In an X post about the interview with Maltz, Bailey said he exposed how “Chinese marijuana grow operations are using hazardous chemicals as pesticides.” In 2022, U.S. Rep. Mike Garcia (R-CA) applauded Bailey, who worked with his office to bring attention to illicit grow operations in his district, leading to a local law enforcement investigation. Bailey gave the congressman credit, saying “your work in taking down the illegal marijuana grows has stopped cartels from exploiting your community, those people forced to work on them and the [money].” In an interview with Fox News’s Sean Hannity in 2021, she also talked about her work with Garcia—including accompanying him on a helicopter to survey “miles and miles and miles of vast, sophisticated illegal grows worth tens of millions of dollars.” Cartels have “become extremely more brazen. They’re not afraid of hiding it,” she said. “They don’t hide it because they don’t feel that they’ll ever be held accountable for it.” In a sense, Bailey has seemed to implicitly suggest at multiple times that she supports regulated access to cannabis as a means of promoting public safety and health. Whether and how that implied position would influence federal policy if she’s confirmed and assumes the ONDCP director role is yet to be seen. On her social media, she’s previously shared links—without commentary—to news stories about a variety of marijuana-related issues. In addition to her focus on illicit cartel grows, she’s also posted about congressional and state-level legalization votes, staffers in the Biden administration being fired over past cannabis use, Democratic presidential candidates’ support for legalization, the advancement of cannabis banking legislation in Congress and state policy developments such as Alaska’s legalization of cannabis cafes. The post Trump’s Drug Czar Pick Dodges Senators’ Marijuana Questions As Her Nomination Advances appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Drug czar nominee advances; FL medical marijuana patient rights bills; Poll: Americans say cannabis healthier than alcohol; Vets lobby for reform Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The latest quarterly tracking poll conducted by Marijuana Moment and NuggMD shows that cannabis consumers are largely unimpressed with President Donald Trump’s actions on the issue so far—and that most believe the CBD video the president posted “does not mean anything” for the prospects of federal rescheduling. The Senate Judiciary Committee advanced the nomination of Sara Carter Bailey—who has voiced support for medical cannabis but declined to endorse rescheduling—to serve as director of the White House Office of National Drug Control Policy. A Florida senator prefiled bills to provide employment and parental rights protections for registered medical marijuana patients for the 2026 session. A new poll of U.S. adults found that 61 percent believe marijuana is a “healthier option” than alcohol and 64 percent expect cannabis to be legal in all 50 states within five years—with majorities also agreeing it has “many health benefits” and legalization is a “good way to add to tax revenue.” The Last Prisoner Project and Balanced Veterans Network launched a lobbying push on Capitol Hill to convince more members of Congress to embrace marijuana reform legislation. “It’s incredible what we can do when the left and right unite for the same mission.” The Sussex County, Delaware Council is considering a proposal to lessen restrictions on marijuana businesses following a request from Gov. Matt Meyer (D). / FEDERAL The Senate rejected a war powers resolution that would have required President Donald Trump to seek congressional authorization before conducting further military strikes on suspected drug cartel members. Sen. Susan Collins (R-ME) cited the issue of “illegal Chinese marijuana grow houses” in a statement announcing her support for President Donald Trump’s nominee to be the U.S. attorney for Maine. Rep. Dave Joyce (R-OH) tweeted, “Loopholes in federal law have allowed some intoxicating hemp products to be improperly labeled and marketed towards our youth. I thank @GovMikeDeWine for taking action to protect Ohio’s children and will continue to advocate for common-sense cannabis reform at the federal level.” / STATES Michigan Gov. Gretchen Whitmer (D) reportedly helped to secure votes to pass a marijuana tax increase through the legislature ahead of its passage. Meanwhile, officials are facing a second lawsuit challenging the new law. A Wisconsin representative discussed her legislation to restrict intoxicating hemp products. A federal court dismissed a lawsuit challenging Washington, D.C. hemp rules. Ohio regulators issued a recall of marijuana products that are not marked with a universal THC symbol on each serving. Massachusetts’s newly reinstated top marijuana regulator said some of the actions other regulators took while she was suspended may have been invalid. The Omaha Tribe of Nebraska’s attorney general spoke about steps toward opening a marijuana dispensary. Oregon regulators proposed changes to rules about an online platform for marijuana and hemp businesses. Arkansas medical cannabis sales have generated $21.5 million to support free meals for students under a new state law. California regulators sent updates on various cannabis issues. Maryland regulators will host a social equity cannabis vendor fair on Friday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL A Yakima County, Washington commissioner authored an op-ed urging voters to approve a ballot measure to keep in place a ban on marijuana businesses. / INTERNATIONAL Thai Prime Minister Anutin Charnvirakul pledged to “win the war on drugs.” Caye Caulker, Belize voters rejected a marijuana legalization referendum. / SCIENCE & HEALTH A study of mice found that a CBD preparation is a “highly efficient, biocompatible, and non-invasive strategy that effectively targets neuroinflammation and addictive behaviors” and “demonstrates significant translational promise for the clinical management of METH addiction.” A study’s results “support the potential of hempseed-derived peptides as dietary modulators of neuroinflammation in early stages of neurodegenerative disease.” / ADVOCACY, OPINION & ANALYSIS The National Right to Work Foundation filed a brief with the U.S. Court of Appeals for the Ninth Circuit arguing that California’s policy of requiring marijuana businesses to enter labor peace agreements violated federal law. The Empire State Green Standard Alliance published a white paper on illegal cannabis product inversion into New York. / BUSINESS Tilray Brands, Inc. reported quarterly net revenue of $209.5 million. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Max Pixel. The post Cannabis consumers disappointed in Trump, poll shows (Newsletter: October 10, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

National Techtools is an Indian supplier founded in 2014, specializing in a wide range of power tools, handyman tools, construction equipment, and accessories for professionals and DIY enthusiasts. Based in Junagadh, Gujarat, they offer thousands of products, including wrenches, saws, drills, grinders, and nail guns, and are known for affordable prices, quality products, and strong after-sales support. https://nationaltechtools.com

National Techtools is an Indian supplier founded in 2014, specializing in a wide range of power tools, handyman tools, construction equipment, and accessories for professionals and DIY enthusiasts. Based in Junagadh, Gujarat, they offer thousands of products, including wrenches, saws, drills, grinders, and nail guns, and are known for affordable prices, quality products, and strong after-sales support. https://nationaltechtools.com

“Intoxicating hemp has no required regulatory testing…and sold in packages enticing to children.” By Megan Henry, Ohio Capital Journal Ohio Gov. Mike DeWine (R) has issued a 90-day executive order banning the sale of intoxicating hemp products starting this coming Tuesday. Intoxicating hemp products are items that contain THC that are sold anywhere other than licensed marijuana dispensaries including gas stations, smoke shops and CBD stores, among others. This ban includes THC-infused beverages. “I am taking action today…to get these products off the streets and to have them taken off our shelves,” DeWine said Wednesday during a press conference. “Intoxicating hemp is dangerous, and we need to better protect our children… We believe this is the right thing to do.” The 90-day executive order ends on January 12, 2026, and then it will be up to the lawmakers to decide if they want to see further action taken on intoxicating hemp. “I’m not going to tell them what to do, but we have to have some control of this product,” DeWine said. “We can’t have a situation where it is legal for people to sell this to underage kids.” Those shops who violate the executive order could be subject to a $500 fine for each day intoxicating hemp products remain on their shelves. The 2018 Farm Bill says hemp can be grown legally if it contains less than 0.3 percent THC. “After these laws were passed, chemists began manipulating compounds in the legal, non-intoxicated hemp plant, turning these compounds into intoxicating THC, including Delta-8 and Delta-9, which are found in marijuana,” DeWine said. “It’s a totally different product.” Marijuana is not considered an intoxicating hemp product and is legal in Ohio. DeWine has been calling on lawmakers to regulate or ban delta-8 THC products since January 2024. He previously said he was not able to sign an executive order about hemp. “We believe we have the authority to do this, and I’m not going to sit back and not do it,” DeWine said, explaining how he went back to his lawyers. It was previously reported Ohio was one of about 20 states that does not have any regulations around intoxicating hemp products, according to an Ohio State University Drug Enforcement and Policy Center study from November 2024. It was reported in January 2024 that there had been at least 257 reports of delta-8 poisoning in Ohio in recent years—including 102 in 2023 and 40 that involved children under six-years-old, according to the Ohio Poison Control Center. “Since intoxicating hemp products, such as delta-8, became widely available, the number of accidental reasonings among children has risen sharply,” said Dr. Hannah Hays, medical director of the Central Ohio Poison Center and Chief of Toxicology at Nationwide Children’s Hospital. Children who ingest intoxicating hemp products can experience drowsiness, hallucinations, confusion, loss of consciousness, seizures, and respiratory failure, Hays said. “I don’t want the product sold to children,” DeWine said. “I think the danger to our children is clear, and I’m taking action today to protect Ohio’s children. These children are vulnerable to these candy knock-off products that are on sale today across the state of Ohio.” DeWine had three intoxicating hemp products with him during Wednesday’s press conference—Stoner Patch Dummies (similar packaging to Sour Patch Kids), Nerdy Bears (similar to Nerds Gummy Clusters), and Sour Infused Gummies (similar to Gushers). “With intoxicating hemp, this product has no restriction on where it can be sold or who can buy it,” DeWine said. “Intoxicating hemp has no required regulatory testing…and sold in packages enticing to children, many times mimicking the packaging of common candies.” A Nerdy Bear gummy bear contains more than 100 milligrams THC, according to the packaging. “For context, many adult produced products will contain 10 milligrams of THC per serving,” DeWine said. “Certainly, it’s easy to see how a child will confuse this product with real candy and eat a few gummy bears and ingest enough THC to require hospitalization.” The Ohio Cannabis Coalition praised DeWine’s executive order. “For too long, the hemp industry has recklessly exploited the Farm Bill loophole to line its pockets at the expense of Ohioans’ health,” OHCANN Executive Director David Bowling said in a statement. “Until today, unregulated synthetic hemp-derived cannabinoids were sold openly, putting consumers, especially children, at risk.” The hemp industry, however, was quick to speak out against DeWine’s executive order. “Governor DeWine’s executive order banning hemp is an attack on Ohio’s consumers who will lose access to safe and legal products, and a gut punch to Ohio farmers and small businesses who have invested tens of millions building legitimate businesses in good faith under existing laws,” Ohio Healthy Alternatives Association Executive Director Michael Tindall said in a statement. He said there are more than 2,000 smoke and hemp shops, and more than 4,000 retailers throughout Ohio that sell hemp products. DeWine’s executive order is a “misguided overreach,” said Jonathan Miller, General Counsel of the U.S. Hemp Roundtable. “We are outraged that the Governor is attempting to bypass the Ohio legislature and misuse executive powers to deliver a crushing, job-killing blow to the state’s hemp industry,” Miller said in a statement. “Instead of prohibition, Ohio should pursue regulation—setting age limits, mandating independent third-party testing, requiring accurate labeling, and ensuring products are made with American-grown hemp.” Dakota Sawyer of American Republic Policy agrees that intoxicating hemp products should not be in the hands of children, but disagrees with DeWine’s approach to ban all products since he said there are stores with age restrictions. “We should be going after the bad actors, but not punishing the good actors,” he said. “This executive order will shut [the good actors] down. This will put them out of business. People won’t be able to put food on their plates for their families.” State Rep. Tex Fischer, R-Boardman, said the executive order is an overstep. “I believe the legislature’s job is to legislate,” he said. “I do not believe it’s the governor’s job to legislate.” Intoxicating hemp products are known to have significant impacts on young, developing brains, yet these products are legally marketed to kids, sold to kids, and ingested by kids in Ohio. Today, I signed an executive order that takes action to keep these dangerous products out of… pic.twitter.com/uAkVT77Sj1 — Governor Mike DeWine (@GovMikeDeWine) October 8, 2025 Intoxicating hemp bills There are a handful of bills in the legislature that would regulate intoxicating hemp products in various ways. Ohio Senate Bill 266 would ban the sale of intoxicating hemp products to people under 21, ban the sale of intoxicating hemp products that have not been tested under the same rules as marijuana and would prevent selling intoxicating hemp products that appeal to children. Ohio Senate Bill 86 would ban intoxicating hemp products sales to anyone under 21, impose a 10 percent tax on intoxicating hemp products and regulate drinkable cannabinoid products. The bill would require intoxicating hemp products to be sold only at adult-use marijuana dispensaries instead of allowing them to be sold at CBD stores, convenience stores, smoke shops, or gas stations. It would require intoxicating hemp products to only be sold if the products have been tested and comply with standards for packing, labeling, and advertising. Ohio Senate Bill 56 would only allow a licensed marijuana dispensary to sell intoxicating hemp products that have been tested and complied with packaging, labeling and advertising requirements. The bill, which passed in the Senate earlier this year, would also change parts of the state’s marijuana law. Ohio House Bill 160 mostly deals with potential changes to the state’s marijuana laws, but it also has an intoxicating hemp provision that would require every THC product to only be sold at Ohio’s regulated marijuana dispensaries. This story was first published by Ohio Capital Journal. The post Ohio Governor Issues Order Banning Intoxicating Hemp Product Sales For 90 Days appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A majority of Americans believe marijuana represents a “healthier option” than alcohol—and most also expect cannabis to be legal in all 50 states within the next five years—according to a new poll. The MRI-Simmons 2025 National Cannabis Study offer a wide range of data points on public opinion and consumer trends concerning marijuana, touching on the economics, health impact and policy considerations for cannabis. One of the more notable findings is that 61 percent of respondents agreed that marijuana is a healthier choice compared to alcohol, which comports with other surveys that reveal shifts in consumer behavior and perceptions of harm. Among people who’ve used marijuana in the past six months, 87 percent said cannabis was healthier than alcohol. “This shift in perception is critical for marketers. Cannabis is no longer competing with tobacco or alcohol, but it’s carving out its own space in the wellness economy,” Emily Williams, a research manager at MRI-Simmons, said. “Brands that position cannabis as part of a holistic lifestyle will resonate with a growing audience that values self-care, mindfulness, and natural remedies.” To that point, the survey also found that 73 percent of U.S. adults believe marijuana carries health benefits, and 67 percent said cannabis is good for both the body and mind. Overall, 62 percent of respondents said that marijuana should be federally legalized, while 64 percent said they expect cannabis to be legal in all 50 states within five years. Asked about related cannabis policy issues, 70 percent said that legalization would help reduce illegal drug trafficking, 63 percent said they back expunging past convictions for cannabis-related offenses and 52 percent voiced support for prioritizing marijuana business licensing for people who have faced the consequences of criminalization. Further, 67 percent of American adults said that banks should be able to service state-licensed cannabis businesses—a reform that’s advanced through the U.S. House of Representatives multiple times but has yet to be enacted. Another 59 percent said they’d be more likely to support a political candidate who backs legalization. Three in four adults (74 percent) said legalization is a “smart way to boost tax revenue,” and 73 percent “see dispensaries as valuable contributors to local economies,” the survey found. And while prohibitionists have frequently argued that support for legalization doesn’t translate into support for allowing cannabis retailers in a person’s community, the poll found that 65 percent are “willing to welcome a dispensary in their own city,” while 54 percent expressed openness to investing in the cannabis industry. As far as cannabis travel experiences are concerned, the poll found that 26 percent of adults are interested in cannabis friendly resorts, 25 percent said the same of marijuana friendly hotels and 21 percent are inclined to visit a cannabis bed-and-breakfast. With respect to cannabis dining experiences, ordering infused items at a restaurant and marijuana social consumption lounges, 20 percent of adults said they’re interested, while 17 percent expressed the same sentiment toward cannabis dispensary bus tours. “As cannabis becomes more mainstream, we can expect continued momentum in legalization, innovation in product development, and expansion into new consumer categories,” Williams said. “The data show that Americans are ready: they want legal access, economic opportunity, and health-conscious options.” Meanwhile, President Donald Trump’s approval rating on marijuana policy remains largely underwater among cannabis consumers, according to the latest quarterly NuggMD-Marijuana Moment tracking poll. And while many stakeholders were encouraged to see the president share a video touting the health benefits of CBD, a majority of consumers don’t see it as an indication the administration will be moving forward with cannabis rescheduling. The quarterly approval survey, as well as a separate flash poll that followed Trump’s CBD post, indicate that, without meaningful action on marijuana rescheduling, many consumers remain skeptical that reform action is imminent—despite the president’s commitment in late August to decide on the issue within weeks. Last month, another poll showed that a majority of Americans don’t consider marijuana dangerous, though most do think consuming cannabis increases the likelihood that people will transition to using more dangerous drugs. A survey from the Coalition for Cannabis Policy, Education, and Regulation (CPEAR), which was conducted by the firm Forbes Tate Partners, showed that seven in 10 American voters want to see the end of federal marijuana prohibition—and nearly half say they’d view the Trump administration more favorably if it took action on the issue. Earlier this year, meanwhile, a firm associated with Trump—Fabrizio, Lee & Associates—also polled Americans on a series of broader marijuana policy issues. Notably, it found that a majority of Republicans back cannabis rescheduling—and, notably, they’re even more supportive of allowing states to legalize marijuana without federal interference compared to the average voter. Photo courtesy of Mike Latimer. The post Most Americans Say Marijuana Is A ‘Healthier Option’ Than Alcohol, And A Majority Expect Nationwide Legalization Within Five Years, Poll Finds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Bless you in the blog post and even very good strategies.. possibly even As i moreover think 6-pack abs is without a doubt a very important facet of gaining achieving success. 강남쩜오 Whoa! Precisely what a close look opener this specific article have been to me. A lot loved, added, My spouse and i can’t loose time waiting for additional! pucuk138 slot

A key Senate committee has given initial approval to President Donald Trump’s pick to serve as White House drug czar, where she will play a central role in implementing the administration’s drug policy agenda that touches on everything from marijuana and psychedelics to harm reduction and overdose prevention. The Senate Judiciary Committee on Thursday advanced the nomination of Sara Carter Bailey to join the administration as director of the Office of National Drug Control Policy (ONDCP). Bailey has voiced support for medical cannabis, while stating that she doesn’t have a “problem” with legalization, even if she might not personally agree with the policy. A former journalist known for her coverage of drug cartels, Bailey also recently advised senators that the administration is keeping “all options” on the table as it continues to consider a pending marijuana rescheduling proposal, while describing cannabis reform as a “bipartisan issue.” The committee voted 12-10 to advance her nomination to the Senate floor. Ahead of the vote, Sen. Dick Durbin (D-IL), the panel’s ranking member, called Bailey a Trump “loyalist” who was “nominated for a position for which she is totally, wholly unqualified.” “She is not a physician or addiction specialist,” he said. “She has never been a prosecutor nor a law enforcement official.” Given the role of the ONDCP director in setting and carrying out the administrative agenda on drug policy issues, the fact that Bailey has gone on the record enthusiastically endorsing medical cannabis in the past is welcome news for advocates. Sen. Cory Booker (D-NJ) separately raised the issue of cannabis rescheduling with the nominee last month, stating that the proposal to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) would represents a “step in the right direction.” “It would open up the door to more scientific study, and so I’m wondering if you were confirmed, how would you advise the American president about the ongoing rescheduling process?” he asked. Bailey said she shares Booker’s passion for the issue, which she characterized as “bipartisan.” “If confirmed as director, I will comply with all federal laws and fulfill all statutory responsibilities of the ONDCP,” she said. “However, we will continue to work extensively with research and data. We will continue to do that and explore all options.” Trump endorsed rescheduling—as well as marijuana industry banking access and a Florida legalization ballot initiative–on the campaign trail ahead of his second term. But his most recent comments in late August about the timeline for a rescheduling decision gave a more ambiguous impression of his position on the issue. While Bailey has spoken often about various marijuana policy issues—focusing attention on illicit trafficking and illegal grow operations on U.S. land, for example—her public comments on how she personally feels about the topic have been limited. What she did say last year in an episode of her podcast, The Sara Carter Show, signaled that she draws a distinction between legally regulated and illicitly supplied marijuana. “I don’t have any problem if it’s legalized and it’s monitored,” she said. “I mean, I may have my own issues of how I feel about that, but I do believe that cannabis for medicinal purposes and medical reasons is a fantastic way of handling—especially for people with cancer and other illnesses, you know—of handling the illness and the side effects of the medication and those illnesses. So I’m not saying we’ve gotta make it illegal.” If Bailey is ultimately confirmed by the Senate, she will become the second drug czar in a row who has voiced support for medical marijuana, following former President Joe Biden’s ONDCP director Rahul Gupta, who worked as a consultant for a cannabis businesses and also oversaw implementation of West Virginia’s medical marijuana program. On her social media, Bailey has previously shared links—without commentary—to news stories about a variety of marijuana-related issues. In addition to her focus on illicit cartel grows, she’s also posted about congressional and state-level legalization votes, staffers in the Biden administration being fired over past cannabis use, Democratic presidential candidates’ support for legalization, the advancement of cannabis banking legislation in Congress and state policy developments such as Alaska’s legalization of cannabis cafes. Federal statute dictates the drug czar is prohibited from endorsing the legalization of Schedule I drugs in the CSA, including marijuana. “The Director…shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of section 812 of this title and take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that— (A) is listed in schedule I of section 812 of this title; and (B) has not been approved for use for medical purposes by the Food and Drug Administration.” In April, however, Democratic congressional lawmakers announced the filing of a bill that would remove that restriction. It has not yet advanced in the GOP-controlled Congress. Bailey has separately sounded the alarm about the risk of pesticides and other contaminants in marijuana grown and sold by Chinese cartels—an issue that was recently taken up by a House committee. Last year, the nominee talked about the issue with Derek Maltz, a then-retired Drug Enforcement Administration (DEA) official who is temporarily served as acting administrator of the agency prior to the confirmation of Trump’s permanent pick, Terrance Cole. In an X post about the interview with Maltz, Bailey said he exposed how “Chinese marijuana grow operations are using hazardous chemicals as pesticides.” In 2022, U.S. Rep. Mike Garcia (R-CA) applauded Bailey, who worked with his office to bring attention to illicit grow operations in his district, leading to a local law enforcement investigation. Bailey gave the congressman credit, saying “your work in taking down the illegal marijuana grows has stopped cartels from exploiting your community, those people forced to work on them and the [money].” In an interview with Fox News’s Sean Hannity in 2021, she also talked about her work with Garcia—including accompanying him on a helicopter to survey “miles and miles and miles of vast, sophisticated illegal grows worth tens of millions of dollars.” Cartels have “become extremely more brazen. They’re not afraid of hiding it,” she said. “They don’t hide it because they don’t feel that they’ll ever be held accountable for it.” In a sense, Bailey has seemed to implicitly suggest at multiple times that she supports regulated access to cannabis as a means of promoting public safety and health. Whether and how that implied position would influence federal policy if she’s confirmed and assumes the ONDCP director role is yet to be seen. On her social media, she’s previously shared links—without commentary—to news stories about a variety of marijuana-related issues. In addition to her focus on illicit cartel grows, she’s also posted about congressional and state-level legalization votes, staffers in the Biden administration being fired over past cannabis use, Democratic presidential candidates’ support for legalization, the advancement of cannabis banking legislation in Congress and state policy developments such as Alaska’s legalization of cannabis cafes. Photo courtesy of Mike Latimer. The post Senators Advance Trump Pick For White House Drug Czar Who’s Voiced Support For Medical Marijuana But Declined To Endorse Rescheduling appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“When the governor calls and says, ‘Would you consider taking a look at this?’, the County Council is certainly open-minded.” By Maggie Reynolds, Spotlight Delaware Sussex County Council will consider easing its restrictions on recreational marijuana sales, some of the toughest in the state, after county officials were nudged by Gov. Matt Meyer (D). Later this fall, council members will consider changing the county’s marijuana zoning ordinance, decreasing the distance required between a marijuana store and a town boundary, as well as the required distance from a school or church. The proposed ordinance change–and Meyer’s request that county leaders consider it–comes two months after recreational marijuana sale was legalized in Delaware. It also follows a decision by the governor earlier this summer to veto a bill that would have limited individual counties’ abilities to restrict marijuana establishment operations. “When the governor calls and says, ‘Would you consider taking a look at this?’, the County Council is certainly open-minded,” Sussex County Administrator Todd Lawson told Spotlight Delaware. Historically, Sussex has been the strictest of Delaware’s three counties on marijuana regulations. Its proposed ordinance changes would bring the southernmost region more in line with the rest of the state. The Governor’s nudge The state legislature passed Senate Bill 75 in June, limiting the restrictions that individual counties could impose on the operation of marijuana establishments. In a surprising departure from his initial support for the bill, however, Meyer vetoed SB 75 in August, citing a belief that local land use decisions should be left up to the counties. When Meyer vetoed the bill, he told Sussex County to look at adjusting its existing marijuana zoning ordinance, which had been in place since the spring of 2024, Lawson told Spotlight Delaware. The proposed ordinance change, which Assistant County Attorney Vince Robertson presented to the County Council on September 23, would reduce the required distance between a dispensary and any town boundary from 3 miles to a half mile. It would also allow dispensaries to operate in less dense commercial areas. Currently, they are only allowed in areas zoned for heavy commercial use, like along Route 1. Council members are also considering decreasing the required 3 miles of separation between dispensaries and schools, churches, substance abuse treatment facilities and other marijuana retail establishments, Robertson said at the September 23 meeting, but the exact details will be left up for discussion at the public hearings on the ordinance. In New Castle County, dispensaries are permitted in commercial areas at least 1,000 feet from “sensitive areas,” like schools and churches, and at least 1 mile from any existing dispensary. Kent County does not have specific retail marijuana regulations, so they are treated like other retail stores in county code, County Planning Director Sarah Kiefer said. All three newly elected members of the County Council–Matt Lloyd, Steve McCarron and Jane Gruenebaum–each expressed early support for the proposed ordinance change when asked by Spotlight Delaware. Council President Douglas Hudson and Vice President John Rieley did not respond to requests for comment on the topic. McCarron said he operates a restaurant neighboring the Fresh Dispensary in Seaford and has been impressed by the professionalism and security of the store, which changed his opinion on retail marijuana shops in the county. “They’ve been a great neighbor,” he said. “I can’t say enough good things about them.” Gruenebaum said she is in favor of the ordinance change because it would bring the marijuana rules closer to the distance requirements for liquor stores, which have a standard regulation under Delaware state code. Liquor stores are permitted in any commercial zone under state code. They must be placed with consideration of churches, schools and substance abuse facilities, Robertson said at the Sept. 23 council meeting, but there is currently no specific distance requirement for liquor stores like there is for marijuana retail stores. The proposed marijuana ordinance will next be discussed at the Sussex County Planning and Zoning public hearing on October 15. Town authority While the marijuana ordinance applies to all unincorporated county land, each town within the county is able to make its own retail marijuana regulations. All of the 25 towns in Sussex County have outlawed retail marijuana entirely, except for Seaford, Georgetown and Frankford. Seaford amended its regulations in late August, allowing Fresh Dispensary, which had been operating only for medical sales since 2023, to begin recreational sales as well on October 4. Justin Weisser, owner of Fresh Delaware, which also has locations in Newark and Milford, said he is pleased to begin recreational business in Seaford, because the store had been losing revenue on medical sales since it opened. “We’re not doing much business medically speaking,” Weisser said. “The store doesn’t make any money right now.” The state had encouraged Weisser’s company to open a medical marijuana location in Seaford because there are not any other medical marijuana dispensaries in western Sussex County, he added. The town of Frankford never passed an ordinance regulating retail marijuana, which allowed The Farm Dispensary to open a medical and recreational store within town limits on July 31, owner Jen Stark said. Stark said the store’s business has primarily been recreational so far, because people have not yet had time to get established on the medical patient list. Frankford Town Manager Sheldon Hudson described the town’s approach of not creating its own marijuana ordinance as being the “salmon swimming up stream” compared to the rest of Sussex County. However, Hudson said he hopes The Farm’s presence will encourage more foot traffic, and in turn bring additional businesses to the town. “We’re looking at it as part of an overall economic development,” he said. Georgetown was the first municipality in Sussex County to allow recreational marijuana, when it passed an ordinance during the summer of 2024 permitting retail sales once the state rules went into effect, Mayor Bill West said. Business, community response In addition to the three recreational marijuana stores operating within town limits in Sussex County, there are two stores operating outside of municipal boundaries near Lewes and Rehoboth Beach, respectively. All of the eastern Sussex beach towns have outlawed retail marijuana within town limits. Management staff at Columbia Care Rehoboth, which has been doing medical sales since 2019, described the addition of recreational sales as overwhelmingly positive for Sussex County residents. “The community as a whole has been extremely responsive, curious–it’s a whole experience,” Supervisor of Retail Operations Sherri Kohler said. Kohler said the store, located at the Tanger Outlets on the west side of Route 1, has attracted a mix of tourists and locals. Lindsay Lopez, the store’s manager of retail operations, said the addition of retail has also allowed the store to nearly double its number of employees. “It’s creating jobs for people who have been passionate about this for a long time, and now they have a platform for community outreach,” Lopez said. Thrive Dispensary, located off Route 9 near Lewes, also added recreational sales on Aug. 1. Emily Wilkins, the store’s vice president of compliance and quality, said she would be eager to consider expanding to another location in Sussex County, if the proposed zoning changes are enacted. Because both Columbia Care and Thrive began operation before 2024, the stores were grandfathered into the previous medical marijuana zoning requirements, before the more strict Sussex County ordinance went into effect in 2024. Wilkins, who described herself as “western Sussex born and bred,” said she does not believe that the current marijuana regulations in the county match the attitude of Sussex County residents toward marijuana use. “I don’t think that the sentiment matches what the government is doing right now,” she said. This story was first published by Spotlight Delaware. Photo courtesy of Chris Wallis // Side Pocket Images. The post Delaware County To Consider Easing Marijuana Business Restrictions In Line With Governor’s Request appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. agenolx daftar Thank you for helping people get the information they need. Great stuff as usual. Keep up the great work!!! bandar toto macau

Many thanks with regard to supplying current improvements concerning the issue, We anticipate study much more. 강남쩜오 This may be a terrific report, Kudos meant for getting my family this level of detail. Always keep ad. slot gacor pucuk138

“It’s incredible what we can do when the left and right unite for the same mission, and yesterday and today were fantastic examples of how bipartisan these particular issues are.” By Josh Kasoff, Filter At the end of September, a lobbying effort on Capitol Hill sought to convince lawmakers of the need to move toward federal cannabis legalization, to free people incarcerated for marijuana convictions and to ensure access, in particular, for veterans impacted by a range of health conditions. Events over two days were coordinated by a pair of nonprofits that share these goals: Last Prisoner Project (LPP) and Balanced Veterans Network (BVN). Their representatives visited over a dozen congressional offices, including those of influential members of the House Committee on Veterans’ Affairs and other Congress members who are veterans. “The main objectives of today and yesterday were to find co-sponsors for numerous federal bills, including the PREPARE Act (H.R. 2935), the Evidence-Based Drug Policy Act (H.R. 3082) and a number of veteran-focused access bills,” Jason Ortiz, LPP’s director of strategic initiatives, told Filter on September 30. The PREPARE Act, introduced in April by Representative Dave Joyce (R-OH), would establish a federal commission to study and advise on ways to regulate cannabis similarly to alcohol. The Evidence-Based Drug Policy Act, introduced the same month by Rep. Dina Titus (D-NV), would repeal a provision of a 1998 act, which bans the Office of National Drug Control Policy from using federal funds to study potential legalization of Schedule I substances—as cannabis remains—and requires the ONDCP to oppose legalization attempts. “Having over a dozen meetings with folks specifically on the Veterans’ Affairs Committee, to bring cannabis issues to that committee, was a huge shift in strategy,” Ortiz said, “and I think it’ll be invaluable moving forward to make sure we can bring on folks that are typically not seen as allies.” Large numbers of United States veterans live with harrowing physical and mental health conditions. In many cases, available pharmaceuticals haven’t helped. Cannabis has given many tremendous relief—and might help far more. But despite research supporting its use for numerous conditions, the Schedule I status of “no currently accepted medical use” means veterans don’t have access through the VA. In this context, veteran suicide rates are distressingly high. Eric Jansen, BVN’s government affairs coordinator, has been personally impacted. On Easter morning 2017, Jansen came home to find his best friend, Army veteran Brad Chartier, dead by suicide. Jansen carried the pain of Chartier’s death for years, he said, until an ayahuasca ceremony gave him closure and a new appreciation for life and advocacy. One matter Jansen discussed with congressional staffers was the disturbing findings of Operation Deep Dive, which indicated that veteran suicide rates were double the commonly stated average of “22 a day.” “These findings expose a much graver reality of veteran suicide and overdose than previously acknowledged, underscoring the urgency of addressing this crisis with new approaches,” Jansen told Filter. While there was camaraderie and humor among the veteran advocates on Capitol Hill, they pressed congressional staffers about a number of injustices. These included cases of veterans who remain incarcerated for nonviolent marijuana convictions—in states where lucrative, legal cannabis marketplaces have since been created. Among the cases are those of Robert Deals, an Air Force veteran serving an 18-year sentence in an Arizona prison; Deshawn Reilly of the Marines, serving a 17-year sentence in Georgia; and Kristofer Fetter, an Army veteran who served in Iraq and received a sentence of nearly five years in New York. Trying to engage with lawmakers can be a long and frustrating process, but Jansen said progress was definitely made. “While it was difficult to meet directly with elected representatives, we were able to engage with their staff, which is a critical first step,” he explained. “Raising awareness is half the battle… Ultimately, the only path to moving legislation forward is through increased co-sponsorship and committee support.” The advocates found some lawmakers particularly receptive. Rep. Tony Wied (R-WI), for instance, who has a small memorial to Chartier in his office, was strongly in favor of the measures discussed. The targeted lawmakers were from both sides of the political aisle, and to match that, the advocates also had mixed political views, coming together in what might strike some as an unlikely alliance. “But really,” Ortiz said, “the main objective was, ‘Can we work together as progressive advocates and [some] Republican veterans to actually have a central message that we can share in unity with Congress to bring them on board?’” “The answer,” he said, “was absolutely yes.” “We crushed every meeting we were a part of, we were well received by members of all parties and we walked out with additional co-sponsors and members of the PATH Caucus moving forward,” Ortiz said, referring to the congressional Psychedelics Advancing Therapies Caucus. “It’s incredible what we can do when the left and right unite for the same mission,” he concluded, “and yesterday and today were fantastic examples of how bipartisan these particular issues are, when we’re talking about cannabis legalization and veterans having access to life-saving treatments.” Jansen agrees with the importance of bipartisanship in making tangible legislative progress. “Bipartisan engagement is absolutely essential,” he said. “Information sharing builds trust, and asking representatives directly what they need from us strengthens our advocacy. Caucuses, by design, are bipartisan, and that dynamic is critical to success. Mental health challenges transcend party lines; this is not a partisan issue, but an American one. To achieve lasting reform, we must bring together support from across the aisle.” This article was originally published by Filter, an online magazine covering drug use, drug policy and human rights through a harm reduction lens. Follow Filter on Bluesky, X or Facebook, and sign up for its newsletter. The post Military Veterans And Prisoner Advocacy Groups Lobby Congress To Change Marijuana Laws appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida senator has filed a pair of bills for the 2026 legislative session that would provide employment and parental rights protections for registered medical marijuana patients. The legislation, introduced by Sen. Tina Scott Polsky (D) on Wednesday, would build upon the state’s existing medical cannabis laws as advocates again attempt to pass adult-use legalization at the ballot next year. One of the new measures, SB 136, would prohibit public employers from taking adverse actions against workers or job applicants over the use of medical cannabis in compliance with state law—or as a result of a positive THC test—if they demonstrate that they’re lawfully registered as a medical marijuana patient. There’s an exemption built into the legislation, stipulating that adverse personnel actions can be taken if there’s “a preponderance of the evidence that the lawful use of medical marijuana is impairing the employee’s ability to perform his or her job duties or responsibilities.” The bill also states that, if an employer mandates drug testing and a worker or job applicant tests positive for THC, that employer must given written notice within five days about their right to explain the circumstances behind their positive test. The worker or applicant could then provide proof of a physician’s recommendation for medical cannabis to explain the drug test results. Nothing in the proposal precludes an employer from enforcing a zero-tolerance policy for the use or possession of a controlled substance, including marijuana, during normal business hours. But if adverse action is taken against the worker or applicant for off-duty cannabis use as a registered patient, the legislation provides for means of recourse, including compensation for lost wages and legal fees. Polsky’s bill also states that employers “must attempt to make reasonable accommodations for the medical needs of an employee who engages in the use of medical marijuana if the employee holds a valid medical marijuana use registry identification card, unless the employer can demonstrate that the accommodation would pose a threat of harm or danger to persons or property, impose an undue hardship on the employer, or prevent an employee from fulfilling his or her job responsibilities.” This is the latest version of the measure, which was filed by Polsky last year but did not advance to enactment. The senator’s other new bill, SB 130, focuses on parental rights, specifying that a court “may not deny or otherwise restrict a parent’s custody of a minor child or the parent’s visitation rights or parenting time with a minor child based solely on the parent’s status as a qualified patient.” “There is no presumption of neglect or child endangerment based solely on the parent’s status as a qualified patient,” it says. “In determining the best interests of the child with respect to custody or dependency, this section applies.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a Florida court recently ruled that police cannot search a person’s vehicle based only on the smell of marijuana. The District Court of Appeal of Florida Second District last week issued an opinion, authored by Judge Nelly Khouzam, overturning a lower court decision that upheld the “plain smell doctrine” that has long permitted cannabis odor to be used as a pretense for vehicle searches. Cannabis reform enjoys majority support in Florida, according to multiple polls that led up to a vote on an adult-use legalization ballot initiative last year. It ultimately fell short of the steep 60 percent threshold for passage, and part of the opposition came from the Florida Police Chiefs Association (FPCA) and the Florida Sheriffs Association (FSA). As of this summer, the renewed legalization campaign has collected more than 75 percent of the required signatures to put the marijuana initiative on the 2026 ballot, according to state officials. Gov. Ron DeSantis (R) said in February that the newest measure is in “big time trouble” with the state Supreme Court, predicting it will be blocked from going before voters next year. Smart & Safe Florida is hoping the revised version will succeed in 2026. The campaign—which in the last election cycle received tens of millions of dollars from cannabis industry stakeholders, principally the multi-state operator Trulieve—incorporated certain changes into the new version that seem responsive to criticism opponents raised during the 2024 push. For example, it now specifically states that the “smoking and vaping of marijuana in any public place is prohibited.”Another section asserts that the legislature would need to approve rules dealing with the “regulation of the time, place, and manner of the public consumption of marijuana.” Last year, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released in February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. However, the results conflict with another recent poll from the Florida Chamber of Commerce, a proactive opponent of legalization, that found majority support for the reform among likely voter (53 percent) but not enough to be enacted under the 60 percent requirement. Another recent poll of Florida Republican voters showed just 40 percent of that demographic said they’d vote in favor of the legalization proposal. In the background of the campaign’s signature development, DeSantis signed a GOP-led bill in June to impose significant restrictions on the ability to put initiatives on the ballot—a plan that could impair efforts to let voters decide on marijuana legalization next year. Photo courtesy of Max Pixel. The post Florida Senator Files Bills To Provide Employment And Parental Protections For Medical Marijuana Patients Ahead Of 2026 Session appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

لا شك أن زيادة متابعين انستقرام تمنح الحساب مظهرًا قويًا وجذابًا، مما يشجع المستخدمين الآخرين على المتابعة والتفاعل مع المنشورات.

President Donald Trump’s approval rating on marijuana policy remains largely underwater among cannabis consumers, according to the latest quarterly NuggMD-Marijuana Moment tracking poll. And while many stakeholders were encouraged to see the president share a video touting the health benefits of CBD, a majority of consumers don’t see it as an indication the administration will be moving forward with cannabis rescheduling. The quarterly approval survey, as well as a separate flash poll that followed Trump’s CBD post, indicate that, without meaningful action on marijuana rescheduling, many consumers remain skeptical that reform action is imminent—despite the president’s commitment in late August to decide on the issue within weeks. All told, a 47 percent plurality of cannabis consumers said they have no opinion or a neutral view of Trump’s marijuana policy actions as of the third quarter of 2025. Another 42 percent said they either disapprove or strongly disapprove, while 11 percent said they approve or strongly approve. That does represent a 4 percentage point improvement in approval from the last quarter, but it remains the case that disapproval outweighs approval by a substantial margin. That could be related to the fact that, while Trump during his campaign last year endorsed rescheduling—as well as marijuana industry banking access—the administration has not yet implemented such reforms so far in his second term. Among self-identified Republicans who use marijuana, Trump’s cannabis policy approval rating plummeted over the last quarter—from net approval/disapproval at 57.2 percent in the second quarter of 2025 to -1.9 percent in the latest quarter. Period Net approval/disapproval: Republican Net approval/disapproval: Democrat Net approval/disapproval: Unaffiliated 2Q25 57.2% -89.3% -43.6% 3Q25 -1.9% -52.7% -32.8% Andrew Graham, head of communications at NuggMD, told Marijuana Moment that “there’s really no sugar-coating a drop that big.” “I would not read this as evidence that millions of Republicans are no longer supporting POTUS because of cannabis policy,” he acknowledged, but said he “would read this as evidence that the lack of progress on cannabis reform is irking Republicans who use the plant, and that, on this issue, POTUS does not have the political durability that he has proven to have on other issues.” “It’s pretty clear, in retrospect, that this portion of the president’s base was animated by promises he made on rescheduling and his support for adult-use in Florida, which ultimately failed,” he said, referencing a state legalization initiative Trump backed on the campaign trail. “Both of those things made news and were part of his 2024 re-election campaign.” Notably, however, the president’s approval on cannabis policy did increase among Democrats and unaffiliated marijuana consumers in the survey as compared to last quarter. Trump’s August comments signaling a forthcoming rescheduling decision “probably drove much of that movement, even though the timeline the White House floated hasn’t been followed,” Graham said. “Do you approve or disapprove of the presidential administration’s actions on cannabis?” n: % Strongly approve 20 3.6% Approve 40 7.1% No opinion/Neutral 266 47.4% Disapprove 111 19.8% Strongly disapprove 124 22.1% 561 Score (-50 to +50) -12.433 Net approve/disapprove: -31.2% The poll, which involved interviews with 561 cannabis consumers who live in states with legal markets from August 29 to September 24 and has a ±4.14 percentage point margin of error, also asked respondents whether they’d be more or less likely to support the administration if rescheduling or legalization was implemented. About 57 percent said they’d be more inclined to support the administration if those reforms were enacted, compared to 43 percent who said it wouldn’t change their view and less than 1 percent who said they’d have a less favorable opinion of the administration. “If the Trump administration were to reschedule or legalize cannabis, would that change your level of support for it?” n: % I would support it much more 244 43.5% I would support it a bit more 71 12.7% No change 244 43.5% I would support it a bit less 2 0.4% I would support it much less 0 0.0% 561 Score (-50 to +50): 24.822 Net approve/disapprove: 55.8% Overall, “the data shows inaction on cannabis policy is costing the president significant political capital,” Graham said. “The portion of his base who consumes cannabis numbers in the tens of millions, and more cannabis consumers currently live in red states than in blue states. Around one in three is politically unaffiliated. It’s a significant audience that, contrary to the stereotype, is not particularly progressive.” The latest quarterly survey was conducted shortly befor the president posted on his Truth Social account a video from The Commonwealth Project that touted the health benefits of CBD, particularly for senior citizens. Some in the industry viewed that as a bellwether of a pro-rescheduling decision soon-to-come. To account for that potential factor, NuggMD ran a separate flash poll in partnership with Marijuana Moment that specifically inquired among cannabis consumers whether they felt the video share signaled it was more or less likely that Trump would be advancing the proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). That survey—which involved interviews with 415 respondents from October 2-7, with a 4.8 percentage point margin of error—found that more than half of marijuana users feel the social media post “does not mean anything in the context of rescheduling.” Last weekend, the president posted a video touting the benefits of CBD for seniors. Some have speculated that this means the administration has decided to reschedule cannabis — which would finally acknowledge that the plant has potential medical benefit — while others say Trump posts about a lot of issues without necessarily signaling policy action. In your opinion, what, if anything, does this news mean for the prospects of rescheduling? n: % It means rescheduling will happen 49 11.8% It means rescheduling is more likely to happen 106 25.5% It does not mean anything in the context of rescheduling 208 50.1% It means rescheduling is less likely to happen 28 6.7% It means rescheduling will not happen 24 5.8% 415 About 37 percent said that the post meant rescheduling either will happen or is more likely to happen, while 13 percent said it signaled the reform would not happen or was less likely to happen. “This data, and our quarterly presidential approval poll more broadly, suggests that the president does not have the political durability on cannabis that he has on other issues,” Graham said. “I don’t think he can kick the can down the road on rescheduling without alienating the portion of his base that uses the plant, because they’re expecting real action.” Meanwhile, several GOP senators recently told Marijuana Moment that, if Trump ultimately moves forward with marijuana rescheduling, it would be a “game changer” for future federal cannabis reform. One of Trump’s longtime advisors, Roger Stone, separately said that his administration has an opportunity to move forward with marijuana rescheduling—or, even broader legalization—in a way that Democrats who regularly tout the reform failed to achieve when they controlled the White House and Congress. The Republican Senate sponsor of a bipartisan cannabis banking bill said recently that Trump rescheduling marijuana would be an “important domino” to advance his legislation. Whether Trump ultimately decides to move forward with rescheduling remains to be seen. Despite his endorsement of the policy change on the campaign trail ahead of his election for a second term, he declined to restate that support when asked about it during a briefing late last month—even though he did say a decision would come within weeks. The post Marijuana Consumers Not Impressed With Trump’s Cannabis Actions So Far—And Most Are Unconvinced His CBD Post Signals Reform, Poll Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. harga toto Thank you for helping people get the information they need. Great stuff as usual. Keep up the great work!!! agenolx I think this is an informative post and it is very beneficial and knowledgeable. Therefore, I would like to thank you for the endeavors that you have made in writing this article. All the content is absolutely well-researched. Thanks... bandar toto macau Thank you for helping people get the information they need. Great stuff as usual. Keep up the great work!!! togel macau Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. agen slot I think this is an informative post and it is very beneficial and knowledgeable. Therefore, I would like to thank you for the endeavors that you have made in writing this article. All the content is absolutely well-researched. Thanks... top orthopedic in Hyderabad

من الملاحظ أن الحسابات النشطة غالباً ما اعتمدت على موقع زيادة متابعين تيك توك في البداية.

I did get pleasure from looking at content put up on this internet site. These are extraordinary and possesses a great deal of valuable data. Buy IPTV Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. bandar toto macau This unique is a fantastic put up I just spotted using show it again. Suggest whatever I wanted to ascertain optimism through forthcoming you are likely to remain for the purpose of showing this terrific put up. bandar togel In fact dependable, fantastic, fact-filled advice in this case. A items Have let down, and that also clearly is valid in this case to boot. Most people consistently can make for a worthwhile read through. How can you show So i am floored?: )#) Cultivate the nice content pieces. bandar slot gacor Used to do delight in examining articles or blog posts placed here. There're outstanding possesses many practical facts. agen slot A beats might be fantastic. You possess numerous especially capable actors. I just aspire most people the right from victory. Investment Scam

TX hemp crackdown; NYC marijuana delivery pigeons stunt; Study: Soil impacts cannabis’s THC & terpenes; Op-ed on stopping inversion this Croptober Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Texas Gov. Greg Abbott (R) is directing the Department of Public Safety to step up enforcement against hemp product violations, including with “undercover operations to identify unlawful activity.” The U.S. Hemp Roundtable sent a letter urging President Donald Trump to stop Congress from recriminalizing products with any amount of THC and “reversing the work you led in 2018 to make hemp blossom” when he signed the crop’s legalization into law. The Travel Agency dispensary confirmed it will not actually be delivering marijuana via carrier pigeons throughout New York City after a marketing stunt fooled several media outlets into reporting the ruse as fact. A new federally funded study shows that cannabis plants grown in various kinds of soil have “significant differences in specific cannabinoid and terpene concentration.” “This is the first study to show differences in extract composition of outdoor cultivated hemp grown in different soil conditions.” Former New York Office of Cannabis Management Chief Equity Officer Damian Fagon argues in a new Marijuana Moment op-ed that if regulators don’t confront the issue of product inversion from other states this “Croptober” with “meaningful oversight,” legalization could “harden into monopoly and fraud.” “The future of craft cannabis, small farmers and equity licensees will be decided by whether officials finally enforce the systems they promised.” The Michigan Cannabis Industry Association filed a lawsuit claiming that a newly enacted marijuana tax increase violates several sections of the state Constitution, including requirements for amending the voter-approved legalization law. The Nebraska Medical Cannabis Commission selected awardees for the state’s first marijuana cultivation licenses, nearly a week after the legal deadline that they were supposed to do so by. / FEDERAL The Justice Department’s Office of Legal Counsel issued an opinion justifying the Trump administration’s military strikes on suspected drug cartel boats. / STATES Ohio Gov. Mike DeWine (R) signed an executive order banning the sale of intoxicating hemp products for 90 days. California Gov. Gavin Newsom (D) signed a bill protecting students from receiving disciplinary action when they call for assistance or are the victims of a drug overdose-related incident. Separately, the state Research Advisory Panel will consider proposed cannabis and psychedelics studies on Friday. Oklahoma Republican attorney general candidate Jeff Starling, currently the secretary of energy and environment, said he would prioritize combatting illegal marijuana cultivation operations if elected. The Washington, D.C. Council passed a bill to extend conditional medical cannabis business licenses by 12 months. Illinois regulators filed proposed changes to cannabis rules. Arizona officials are accepting applications for grants to support research on ibogaine. Guam regulators reported that medical cannabis patient registrations are declining. New Jersey regulators posted tips for marijuana business license applicants. Minnesota regulators sent a newsletter with updates on various cannabis issues. The Rhode Island Cannabis Advisory Board will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Denver, Colorado officials are accepting applications for the Cannabis Entrepreneurship Technical Assistance Program. / INTERNATIONAL Germany’s Cabinet approved a proposal to add restrictions to the country’s medical cannabis program. British Columbia, Canada’s premier said the province’s drug decriminalization experiment was “not the right policy.” / SCIENCE & HEALTH A study found that “cannabis legalization and dispensary openings did not significantly impact motor accident rates during the study period.” A study of rats found that “CBD-impregnated mesh implants exhibited a lower incidence of bacterial infections compared to the control group.” / ADVOCACY, OPINION & ANALYSIS A poll of Pennsylvania adults commissioned by the American Trade Association for Cannabis & Hemp found that 87 percent believe intoxicating hemp products are regulated in the state. Fox News host Laura Ingraham did a segment on marijuana-impaired driving, saying, “How many more need to die before we call it what it is—dangerous?” / BUSINESS Innovative Industrial Properties, Inc. closed on a new $100 million secured revolving credit facility. / CULTURE Seth Rogen spoke about how the first award he ever won was High Times Stoner of the Year. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Trump pressed to stop Congress from recriminalizing hemp (Newsletter: October 9, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net